This is a working overview of receptor targets, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-09-18 and is reviewed periodically as new material appears.
Published information places retatrutide in clinical development rather than on the market as an approved therapy. Early-stage and mid-stage trials have examined tolerability and changes in body weight, and larger studies continue to report results over time. Open questions include the durability of effects after treatment stops, the composition of weight lost, and cardiovascular outcomes over long periods. Statements about definitive benefit should therefore be treated as provisional. Regulatory status varies by jurisdiction and changes as applications are reviewed.
Retatrutide is an investigational synthetic peptide designed to activate three distinct receptor systems within a single molecule. Its pharmacological profile combines activity at the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This arrangement places it within a broader class of agents often described as multi-agonists, which contrast with compounds that engage one or two targets. Research interest centers on whether simultaneous signaling produces effects that single-receptor agonists cannot achieve alone. A single molecular entity also simplifies manufacturing and delivery logistics compared with combining separate agents.
Mechanistic proposals link each receptor to a different physiological role. Activation of the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors is associated with reduced appetite, slower gastric emptying, and glucose-dependent insulin release. Glucagon receptor signaling, by contrast, is associated with increased energy expenditure and altered lipid handling, though it can also raise blood glucose. The design intent is to balance these contributions so that weight reduction is enhanced without unacceptable glycemic trade-offs. How well that balance holds across individuals is not fully resolved.
Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Studied for metabolic indications |
| Receptor activity | GIP, GLP-1, and glucagon | Single molecule, three targets |
| Development status | Investigational | Not an approved therapy |
| Common synonym | LY3437943 | Development designation |
| Administration route | Subcutaneous injection | As used in clinical studies |
Solid peptide is generally held as a lyophilised powder at low temperature to slow degradation, with desiccant to limit moisture uptake. Reconstituted solutions are less stable and are usually kept refrigerated and protected from light for short periods. Repeated freeze-thaw cycles are avoided because they encourage aggregation. Laboratory handling includes work in a fume hood or laminar flow cabinet to limit inhalation and contamination. Weighing and transfer steps are performed with antistatic tools to reduce static-driven loss of fine powder.
Characterising a peptide of this size relies on a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact molecule from related impurities, while electrospray mass spectrometry confirms molecular mass and detects truncation or oxidation products. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates modified residues. Because the molecule carries a lipid chain, assays must also distinguish the correctly conjugated product from incompletely acylated species.
稳定性研究一般关注脱酰胺、氧化与聚集三类降解路径。脱酰胺多发生在天冬酰胺残基上，氧化常涉及甲硫氨酸与色氨酸，聚集则与浓度、温度以及容器界面接触有关。强制降解实验用于识别分子中较敏感的位点。这些结果会直接影响储存条件的设定与有效期的判断。
冻干粉通常在低温环境下保存，复溶之后需要按指定条件在较短时间内使用。反复冻融和剧烈振荡可能促进聚集，低吸附容器则能减少多肽在管壁上的损失。批号、日期与处理条件的完整记录，是后续复核与问题追溯的基础。
=== Other uses in science === Electron transport chain, a sequence of chemical reactions yielding the transport of an electron through a membrane Food chain, a hierarchical or recursive list of predators and prey
== Conception and development == Freeze branding was conceived and developed in the mid-1960s by Prof. Roy Keith Farrell. He was then a lecturer at the Veterinary College housed within Washington State University Pullman. Farrell had been inspired by his failure to preserve viable cells under cryogenic conditions. He reasoned that if extremely cold temperatures could ruin cell viability in storage then these temperatures ought to be able to produce the same effect in a living animal, specifically the melanocytes that pigment the growing hair as it leaves the follicle. This was the idea Farrell then tested on the College's herd animals. His success with a variety of subjects including cattle, dogs and squirrels and coolants such as dry ice and liquid nitrogen led him to promote the technique as Cryo-Branding. In 1968 Farrell received patent number 3,362,381 for his Cryo-Branding technique. He granted the Federal Government a permanent non-commercial license. Beverly Pat Farrell, wife of the inventor, (both went by their middle names) would go on to create the popular Alpha-Angle Freeze Mark branding system in the early 1970s. For more on her invention, see Freeze brand § Pat Farrell's Alpha-Angle Freeze Mark below. The cryo-branding technique was first used on a commercial scale under license from Farrell in 1966, initially in Sweden and the year after in the UK.
Kardashev mentions another hypothesis that, in his opinion, is capable of explaining the dynamics of the supercivilizations: the "feedback effect" (theorized by Sebastian von Hoerner in 1975), which is based on the hypothesis that at a high technological level, civilizations tend to converge rather than to isolate themselves. The distance between supercivilizations could then be determined by half the time of the technological evolution of the oldest civilization, which would be about 3 to 4 billion years. On the other hand, this supercivilization may not have been present in our galaxy for a long time. Kardashev concludes by saying that since the expansion of the Universe is infinite, the number and lifetime of such supercivilizations are also infinite.
Size of the tumor: larger tumors tend to have a worse prognosis compared to smaller tumors. Spread of tumor to surrounding tissues: tumors that have spread locally to surrounding tissues tend to have a worse prognosis compared to tumors that have not spread beyond their place of origin. Stage and presence of metastases: tumors that have spread ("metastasized") to the lymph nodes (which is rare for bone sarcomas) or other organs or tissues (for example, to the lungs) have a worse prognosis compared to tumors that have not metastasized. Tumor grade: higher grade tumors (grades 2 and 3) tend to have a worse prognosis compared to low grade (grade 1) tumors. Skeletal location: tumors originating in the spine or pelvic bones tend to have a worse prognosis compared to tumors originating in arm or leg bones. For soft-tissue sarcomas other than GISTs, factors that affect prognosis include:
Sources: en.wikipedia.org
Agnolín, Bogan & Lucero (2026) consider Balaena pampaea, Notiocetus romerianus and N. platensis to be nomina dubia, interpreting the fossil material of N. platensis as remains of an indeterminate baleen whale, and interpreting fossils of B. pampaea and N. romerianus as remains of an indeterminate balaenid. Lambert et al. (2026) report shark feeding traces on bones of cetacean specimens from the Pliocene Kattendijk Formation (Belgium), including evidence of a bluntnose sixgill shark feeding on a right whale Balaenella brachyrhynus and evidence of Carcharodon plicatilis feeding on a member of the genus Casatia. López-Galán, Ferrón & Botella (2026) study ecomorphological variation of extant and extinct filter-feeding cetaceans, pachycormiform fishes and selachians, interpreting members of the three groups as repeatedly converging toward analogous functional designs, but also interpreting their convergent evolution as influenced by lineage-specific constraints.
A study of iron-deficiency among early Mongolian nomads showed that although overall rates of cribra orbitalia declined from 28.7 percent (27.8 percent of the total female population, 28.4 percent of the total male population, 75 percent of the total juvenile population) during the Bronze and Iron Ages, to 15.5 percent during the Hunnu (2209–1907 BP) period, the rate of females with cribra orbitalia remained roughly the same, while incidence among males and children declined (29.4 percent of the total female population, 5.3 percent of the total male population, and 25 percent of the juvenile population had cribra orbitalia). This study hypothesized that adults may have lower rates of cribra orbitalia than juveniles because lesions either heal with age or lead to death. Higher rates of cribia orbitalia among females may indicate lesser health status, or greater survival of young females with cribia orbitalia into adulthood.
The same day, the US military announced it struck Iranian military surveillance infrastructure, communication systems, air defense sites, drone storage facilities, and minelayer capabilities at the commander-in-chief's direction in retaliation to another alleged Iranian attack against a ship in the Hormuz. Trump accused Iran of repeatedly violating the ceasefire memorandum, expressing doubt about their ability to learn from past mistakes. He warned of a potential point where the US will be forced to militarily "complete the job", stating that if this occurs, the Iranian regime could cease to exist. On 28 June, Iran said it fired ballistic missiles and drones towards the US Ali Al Salem Air Base in Kuwait and the US Fifth Fleet headquarters in Bahrain in retaliation to American attacks against five Iranian coastal sites. On 8 July, the ceasefire agreement between the US and Iran broke after Iran launched attacks on commercial vessels in the Strait of Hormuz to assert Iranian sovereignty over the Strait of Hormuz, startling US officials and shattering a brief diplomatic calm.
Actinides are typical metals. All of them are soft and have a silvery color (but tarnish in air), relatively high density and plasticity. Some of them can be cut with a knife. Their electrical resistivity varies between 15 and 150 μΩ·cm. The hardness of thorium is similar to that of soft steel, so heated pure thorium can be rolled in sheets and pulled into wire. Thorium is nearly half as dense as uranium and plutonium, but is harder than either of them. All actinides are radioactive, paramagnetic, and, with the exception of actinium, have several crystalline phases: plutonium has seven, and uranium, neptunium and californium three. The crystal structures of protactinium, uranium, neptunium and plutonium do not have clear analogs among the lanthanides and are more similar to those of the 3d-transition metals. All actinides are pyrophoric, especially when finely divided, that is, they spontaneously ignite upon reaction with air at room temperature. The melting point of actinides does not have a clear dependence on the number of f-electrons. The unusually low melting point of neptunium and plutonium (~640 °C) is explained by hybridization of 5f and 6d orbitals and the formation of directional bonds in these metals.
== Pharmacokinetics == The molecular weight, bioavailability, protein binding, elimination half-life, the time to achieve maximum plasma concentration and binding affinity are present in the table below.
Sources: en.wikipedia.org
It is described as a single molecule that acts at three receptors: the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This triple activity distinguishes it from agents that target one or two of these pathways.
It is characterized in the literature as an investigational agent under clinical study. Approval status depends on jurisdiction, and readers should check current regulatory information rather than assume availability.
The combination is intended to pair appetite-related and glucose-related effects with mechanisms that increase energy expenditure. Whether the combined profile offers advantages over simpler agonists is the subject of ongoing research.
Retatrutide is an investigational peptide that activates the GLP-1, GIP, and glucagon receptors at the same time. It is being studied for obesity and type 2 diabetes and has not been approved for clinical use. The internal code LY3437943 refers to the same molecule.